PROFESSIONAL EDITION

The largest community of pharma leaders

Regulatory Affairs

US FDA Accepts GC Pharma’s Biologics License Application for Immune Globulin 'GC5107'

YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced that the United States Food and Drug Administration (FDA) accepted the company’s Biologics License Application (BLA)...

Recent Articles